MedPath

BAYER AG

BAYER AG logo
πŸ‡©πŸ‡ͺGermany
Ownership
Public
Established
1863-08-01
Employees
99.7K
Market Cap
$30.1B
Website
http://www.bayer.com
Clinical Trials
Related News

China Betaferon Adherence, Coping and Nurse Support Study

Completed
Conditions
Multiple Sclerosis, Chronic Progressive
Interventions
Drug: Interferon beta-1b (Betaseron, BAY86-5046)
First Posted Date
2011-09-20
Last Posted Date
2016-09-05
Lead Sponsor
Bayer
Target Recruit Count
110
Registration Number
NCT01436838

Bioequivalence Study in Healthy Subjects, 2*5 mg Tablets Rivaroxaban Versus 1*10 mg Tablet Rivaroxaban

Phase 1
Completed
Conditions
Therapeutic Equivalency
Interventions
Drug: Rivaroxaban (Xarelto, BAY59-7939)
First Posted Date
2011-09-19
Last Posted Date
2015-04-22
Lead Sponsor
Bayer
Target Recruit Count
28
Registration Number
NCT01436526

LCS12 Adolescent Study

Phase 3
Completed
Conditions
Contraception
Interventions
Drug: Skyla (Levonorgestrel, BAY86-5028)
First Posted Date
2011-09-14
Last Posted Date
2015-07-27
Lead Sponsor
Bayer
Target Recruit Count
304
Registration Number
NCT01434160

Risk of Acute Liver Injury in Users of Antimicrobials

First Posted Date
2011-09-14
Last Posted Date
2014-07-08
Lead Sponsor
Bayer
Target Recruit Count
1299056
Registration Number
NCT01434173

Actual Use Trial of Naproxen Sodium

Phase 3
Completed
Conditions
Pain
Interventions
Drug: Naproxen Sodium ER (BAYH6689)
First Posted Date
2011-09-02
Last Posted Date
2015-10-15
Lead Sponsor
Bayer
Target Recruit Count
778
Registration Number
NCT01427803

Evaluate Onset of Action of a Fast Release Aspirin

Phase 3
Completed
Conditions
Healthy Subjects
Interventions
Drug: Acetaminophen (Tylenol extra strength)
Drug: Acetylsalicyclic acid (Fast release Aspirin, BAY1019036)
Drug: Placebo
First Posted Date
2011-08-19
Last Posted Date
2018-12-19
Lead Sponsor
Bayer
Target Recruit Count
510
Registration Number
NCT01420094

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan

Completed
Conditions
Hyperphosphatemia
Interventions
Drug: Lanthanum Carbonate (Fosrenol, BAY77-1931) - chewable tablet
First Posted Date
2011-08-18
Last Posted Date
2020-05-20
Lead Sponsor
Bayer
Target Recruit Count
3267
Registration Number
NCT01419327

Community-Acquired Pneumonia (CAP) Surveillance

Completed
Conditions
Pneumonia
Interventions
Other: No Drug
First Posted Date
2011-08-15
Last Posted Date
2013-11-05
Lead Sponsor
Bayer
Target Recruit Count
560
Registration Number
NCT01416506

Observational Study of Ultravist in Patients Requiring CECT

Completed
Conditions
Diagnostic Imaging
Interventions
Drug: Iopromide (Ultravist, BAY86-4877)
First Posted Date
2011-08-12
Last Posted Date
2015-01-21
Lead Sponsor
Bayer
Target Recruit Count
11660
Registration Number
NCT01415414

Mirena Post-marketing Surveillance in Japan

Completed
Conditions
Contraception
Interventions
Drug: Levonorgestrel IUS (Mirena, BAY86-5028)
First Posted Date
2011-08-11
Last Posted Date
2014-01-09
Lead Sponsor
Bayer
Target Recruit Count
567
Registration Number
NCT01414140
Β© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy